济南龟头表皮发白济南早泻怎样才能治好,济南生殖器红肿怎么消肿,济南早泄什么中药治疗,济南突然硬不了怎么回事,济南前列腺炎治疗方式,济南龟头敏感射精早怎么办,济南为何时间越来越短

While political pundits pontificate about Tuesday’s election results, thousands of high school students around the country will have been hard at work forecasting their own.In a March Madness-style round-robin challenge, students pick states they think will go Democrat or Republican, filling out their own electoral map and entering it among thousands of others in the FANschool Challenge.“It’s something fun. It’s something different that the kids can kind of get a little competitive about,” said high school government and economics teacher Gerald Huesken. “[It’s] friendly academic competition.”Huesken helped start the challenge along with two other colleagues four years ago as the country was gearing up for the 2016 election between Donald Trump and Hillary Clinton. Several of his students correctly predicted the Trump victory despite polls reflecting a different outcome. Back then, he says, it was only something for his class to do as they take what they learn in their civics and apply it to real-life situations, but now, it has exploded into an online format used by hundreds, if not thousands, of teachers across the country, says Huesken.“Right now, we’re looking at the different data from NBC, ABC, stuff like that [to guide our knowledge],” said Huesken. “It’s saying it’s looking pretty good for Joe Biden, but we thought that going into 2016.”Students get to draft states in a fantasy football format. They then learn about what is important to their voters, research news articles and polls, and then predict what they think will happen in 2020 based on what they find, putting together their minds and entering the bracket in a nationwide challenge for prizes.“I have both Florida and Ohio going Republican this year and giving Trump some votes,” said Mason, a junior in Huesken’s class who did not want to use his last name. “I also have Michigan going to Biden, leading him to a pretty comfortable victory.”Mason says the challenge has taught him how different regions of the United States approach different issues and how voting patterns change among different demographics.“If you asked me in 20 words or less why do you teach this course, it’s really because I feel like high school students, whether or not they’re voters, look at our political system and our political institutions and feel like they have no agency,” said Chris Stewart, a social studies teacher at a high school in St. Paul, Minnesota. Stewart helped start the challenge alongside Huesken and used it to helped formulate his fantasy politics course that he only offers during election years as a way to make the electoral process more relatable to many students who are not able to engage in the political process because they are not old enough to vote. 2764

While most people seek safety during danger, Ebonique Johnson actually hurries to the frontlines.“I’m running towards it because that’s where I’m needed the most,” said Johnson, a nursing student at Georgia State University in Atlanta.Set to graduate in December, she’s looking to land a job at an ICU.“I want to be where I’m needed,” Johnson said. “I want to help the COVID patients.”That help could come sooner or later depending on where she gets a job.Some states are waiving certain regulations and allowing nursing students to enter the workforce more easily. Other states, however, have prevented nursing students from working with COVID-19 patients altogether.“We can’t hit the pause button with what’s going on, nurses are needed now more than ever,” said Dr. Regena Spratling, associate dean for GSU’s school of nursing.She says coronavirus concerns have limited student access to hospitals for hands-on clinical training and that more courses are now being taught online.“We’re really focusing on what they would be doing within the health care system as far as taking care of patients,” Spratling said. Despite changes, GSU is seeing more people looking to join its nursing program.For GSU nursing student Phillip Parnell, this pandemic is personal.“One of my older relatives recently passed away with the virus,” he said.The army veteran is now making his second career his first priority.“When it hits home, it’s a different level of intensity,” Parnell said.The Bureau of Labor Statistics says the health care industry needs more than 200,000 new nurses each year through 2026 just to replace retiring nurses.“Although we never thought we would see a pandemic in our lifetime, it’s here,” Johnson said.GSU students are happy to be leading the next generation of nurses while also fighting COVID-19 on the frontlines.“We answer the call to be there for people,” Johnson said. “It’s our time to show up.” 1925

White House chief of staff John Kelly says he will "absolutely not" apologize for his comments on Rep. Frederica Wilson, adding that he stands by his comments.President Donald Trump and the Florida Democratic congresswoman publicly fought over each of their accounts of the conversation the President had with the widow of a slain soldier. Following Wilson's criticism, Kelly had spoken in defense of Trump at the White House press briefing, where he also recounted his own experience from when his own son was killed in action.When defending Trump in the wake of the feud, Kelly claimed Wilson had boasted of securing " million" in federal funding to build a new FBI field office in Miami during the dedication ceremony for the building in 2015. He also called the congresswoman an empty barrel, saying her remarks focused more on her own actions than the heroism of the two FBI agents for whom the new building had been named. 939

While the race to develop a safe coronavirus vaccine is on, there's new evidence other vaccines could help people survive the virus.A husband and wife professor team from Louisiana State University and Tulane University worked together on research about the MMR vaccine. That stands for measles, mumps and rubella.Most children get the vaccine. It could explain why kids are less impacted by COVID-19.Testing on mice found these kinds of "live" vaccines boosted cells' ability to fight off sepsis.Sepsis is ultimately what's causing organ problems and inflammation in many adults who have contracted the novel coronavirus.“The idea behind it is, if these live attenuated vaccines are inducing the cells that will inhibit or dampen the sepsis, that gives the regular immune response time enough to get rid of the infection,” said Dr. Paul Fidel, a professor at LSU.The results of the "live" vaccine test on mice were undeniable.Researchers also point to what happened on the USS Roosevelt, where more than 1,200 sailors contracted the virus. A few were hospitalized and one died.All U.S. Navy recruits get MMR vaccinations.The professors are starting a grassroots campaign for adults to get the MMR booster.“If we're right, wow you would have the cells that would inhibit or dampen the sepsis if you ever got infected with COVID and if we're wrong, so OK you have a booster for MMR and that can’t hurt you at all,” said Fidel.“I think this concept with live attenuated vaccines inducing this response that controls the inflammation as opposed to targeting the actual viral infection, it’s going to serve as a stop gap measure until we get a real legitimate vaccine developed that’s been shown to be efficacious and safe,” said Dr. Mairi Noverr, a professor at Tulane’s school of medicine.The MMR vaccine theory is being tested on primates now. There's a push for human trials, especially with health care workers and people in nursing homes. 1948

When he was diagnosed with two autoimmune diseases, Joel Hechler knew he’d be in for a battle. He didn’t realize maybe his toughest one would be with his insurance company.“I think they put the dollars ahead of a patient’s health,” Hechler said. “I don’t think they fully understand the impact the medicine will have on my long-term health and well-being."Hechler suffers from Crohn’s disease and ulcerative colitis, diseases that attack the lining of his digestive tract. Autoimmune conditions like his can’t be cured but, with the right medication, the symptoms can be controlled.  Finding the right medicine can be hard for those suffering from autoimmune diseases. Even if there are scores of drugs on the market, some patients might only respond to one. In Joel’s case, his doctor thought he’d have a better chance trying a drug called Remicade.“I received a letter from my insurance company that denied the Remicade on the basis that I have to try a different drug before I can get to Remicade," Hechler said.Hechler's insurance company, Premera Blue Cross, wouldn’t approve the drug his doctor prescribed because they wanted him to try a cheaper one first.It’s part of a program that health insurers nationwide use called step therapy, requiring that patients try less-costly drugs before “stepping up” to more expensive ones — even if doctors believes the cheaper drug won’t work.Dr. Larry Adler is president of Huron Gastro in Ypsilanti, Michigan and says he spends virtually every day battling insurance companies over step therapy drugs.“They have to fail this medicine first before they get the new drug,” Adler said. “That doesn’t make any sense.”Adler says it's common for patients to get sicker while waiting for step therapy to run its course.In Hechler's case, it took six weeks of fighting with his insurer to convince them that the cheaper drug wouldn’t be effective. As he was waiting, he was getting worse.“It got to the point where I had to be admitted to the hospital,” Hechler said. "I was very, very sick.”Step therapies are used by insurers to try to control skyrocketing prescription medicine costs, says Glen Perry, Director of Pharmacy Contracting and Sales for Blue Cross Blue Shield of Michigan.“These drugs can cost up to 0,000 per year. These are not cheap medications,” Perry said.“It seems like you’re telling patients that, in many cases, your insurer knows what’s best for you, rather than your doctor,” Jones said.“We are trying to provide the most cost effective and safe medication use,” Perry said, adding that when a doctor and insurer disagree over a drug, they can usually resolve the case within a few days without putting a patient at serious risk.“A delay of one or two days I don’t think is really going to make that much of a difference for the medical outcome of the patient," he said.But for many patients, like Phyllis Toole, the delay is longer than a few days.Phyllis suffers from rheumatoid arthritis, a condition where her body attacks her joints. When her doctor wanted to put her on Orencia, her insurance company HAP said she needed to first try a less expensive drug, Humira.But Phyllis’ doctor was worried about possible side effects and thought Humira could be risky.After battling for months, Phyllis says the whole thing made her feel more like a number than a patient. With her doctor and insurer in a standoff, she was forced to rely on samples of the drug she got from her doctor. HAP never approved her prescription.“They’re playing doctor, is what it feels like,” Toole said. “They’re saying this is what you can have for the symptoms you have. It may make you sicker, but this is what you can have.”HAP issued the following statement to Scripps station WXYZ in Detroit: 3800